Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Anorectal Function & Pelvic Floor Dysfunction
What is the role of Botox for pelvic floor dyssynergia?
Especially in Type 1 and Type 2 dyssyergic defecation.
Answer from: at Community Practice
No personal experience, but there is clinical trial data to support the thought that the quality of the data is poor.
Sign In
or
Register
to read more
29857
Related Questions
In patients with F2/F3 fibrosis, would you start Resmetirom if they had normal liver enzymes?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
What patient characteristics guide the selection of a step-up versus a step-down elimination diet strategy in the management of eosinophilic esophagitis?
Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?
In a patient with Zieve's Syndrome and alcohol related cirrhosis which antibiotic regimen is safe to treat H. pylori?
Do you recommend CBD cessation prior to screening of liver enzymes?
Do you have any concerns about lower extremity compression (e.g., compression stockings, intermittent pneumatic compression, etc.) worsening ascites in a patient with portal hypertension?
What is your preferred first-line regimen to treat a severe or fulminant C difficile infection?
How would you approach endoscopic diagnosis and treatment of an area of visible nodularity concerning for cancer within long segment Barrett’s esophagus?
Are there cirrhotic patients in whom you might withhold or shorten duration of prophylactic antibiotics after UGIB?